237 related articles for article (PubMed ID: 8436398)
1. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.
Breese E; Braegger CP; Corrigan CJ; Walker-Smith JA; MacDonald TT
Immunology; 1993 Jan; 78(1):127-31. PubMed ID: 8436398
[TBL] [Abstract][Full Text] [Related]
2. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.
Melgar S; Yeung MM; Bas A; Forsberg G; Suhr O; Oberg A; Hammarstrom S; Danielsson A; Hammarstrom ML
Clin Exp Immunol; 2003 Oct; 134(1):127-37. PubMed ID: 12974765
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.
Fiocchi C; Hilfiker ML; Youngman KR; Doerder NC; Finke JH
Gastroenterology; 1984 Apr; 86(4):734-42. PubMed ID: 6607860
[TBL] [Abstract][Full Text] [Related]
5. [Colonic expression of gamma-interferon and interleukin-10 in Crohn's disease and ulcerative colitis].
Kallel L; Boubaker J; Louzir H; Ben Ahmed M; Sassi A; Boubaker S; Zouari B; Filali A
Presse Med; 2005 Jan; 34(1):8-12. PubMed ID: 15685091
[TBL] [Abstract][Full Text] [Related]
6. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
Kugathasan S; Saubermann LJ; Smith L; Kou D; Itoh J; Binion DG; Levine AD; Blumberg RS; Fiocchi C
Gut; 2007 Dec; 56(12):1696-705. PubMed ID: 17682002
[TBL] [Abstract][Full Text] [Related]
7. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease.
Breese EJ; Michie CA; Nicholls SW; Williams CB; Domizio P; Walker-Smith JA; MacDonald TT
Aliment Pharmacol Ther; 1995 Oct; 9(5):547-52. PubMed ID: 8580276
[TBL] [Abstract][Full Text] [Related]
8. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
[TBL] [Abstract][Full Text] [Related]
9. Enhanced interferon-gamma production and B7-2 expression in isolated intestinal mononuclear cells from patients with Crohn's disease.
Noguchi M; Hiwatashi N; Liu Z; Toyota T
J Gastroenterol; 1995 Nov; 30 Suppl 8():52-5. PubMed ID: 8563891
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.
Gurbindo C; Sabbah S; Menezes J; Justinich C; Marchand R; Seidman EG
J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):247-54. PubMed ID: 8271122
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of interleukin 17 in inflammatory bowel disease.
Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y
Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
[TBL] [Abstract][Full Text] [Related]
12. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
Kusugami K; Youngman KR; West GA; Fiocchi C
Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
[TBL] [Abstract][Full Text] [Related]
13. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
[TBL] [Abstract][Full Text] [Related]
14. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis.
Mullin GE; Lazenby AJ; Harris ML; Bayless TM; James SP
Gastroenterology; 1992 May; 102(5):1620-7. PubMed ID: 1568572
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
[TBL] [Abstract][Full Text] [Related]
16. Cytokine gene expression in intestinal tuberculosis and Crohn's disease.
Pugazhendhi S; Jayakanthan K; Pulimood AB; Ramakrishna BS
Int J Tuberc Lung Dis; 2013 May; 17(5):662-8. PubMed ID: 23575333
[TBL] [Abstract][Full Text] [Related]
17. Polarized production of T-helper cell type 1 cells in Peyer's patches in Crohn's disease.
Kudo T; Nagata S; Aoyagi Y; Suzuki R; Matsuda H; Ohtsuka Y; Shimizu T; Okumura K; Yamashiro Y
Digestion; 2004; 70(4):214-25. PubMed ID: 15627769
[TBL] [Abstract][Full Text] [Related]
18. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation.
Karttunnen R; Breese EJ; Walker-Smith JA; MacDonald TT
J Clin Pathol; 1994 Nov; 47(11):1015-8. PubMed ID: 7829675
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.
Sato T; Nakai T; Tamura N; Okamoto S; Matsuoka K; Sakuraba A; Fukushima T; Uede T; Hibi T
Gut; 2005 Sep; 54(9):1254-62. PubMed ID: 16099792
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.
Hölttä V; Klemetti P; Salo HM; Koivusalo A; Pakarinen M; Westerholm-Ormio M; Kolho KL; Vaarala O
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):287-92. PubMed ID: 23974060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
